A Study of CS060380 Tablets in Patients With MASH and Obesity
Conditions
Metabolic Dysfunction-associated Steatohepatitis (MASH) · Obesity
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Nanjing Jiangning Hospital, Nanjing, Jiangsu, China
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Shanghai First People's Hospital, Shanghai, Shanghai Municipality, China
Tongren Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Contact: Study coordinator (Xiaohong Wu)The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China
Contact: Study coordinator (Li Li)The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Study leads
Weiqing Wang, Ph.D.
Principal Investigator
Ruijin Hospital